Cargando…

Hair Zidovudine Concentrations Predict Virologic Outcomes Among People Living with HIV/AIDS in China

BACKGROUND: Hair antiretroviral concentrations are an objective and non-invasive measure of adherence to long-term antiretroviral therapy (ART) and can further predict virologic outcomes among people living with HIV/AIDS (PLWH). Zidovudine, one of the mainstream antiretrovirals in China, has been ve...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yan, Liu, Shuaifeng, Chu, Liuxi, Zhang, Quan, Yang, Jin, Qiao, Shan, Li, Xiaoming, Zhou, Yuejiao, Deng, Huihua, Shen, Zhiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357394/
https://www.ncbi.nlm.nih.gov/pubmed/35945983
http://dx.doi.org/10.2147/PPA.S371623
_version_ 1784763704714199040
author Wu, Yan
Liu, Shuaifeng
Chu, Liuxi
Zhang, Quan
Yang, Jin
Qiao, Shan
Li, Xiaoming
Zhou, Yuejiao
Deng, Huihua
Shen, Zhiyong
author_facet Wu, Yan
Liu, Shuaifeng
Chu, Liuxi
Zhang, Quan
Yang, Jin
Qiao, Shan
Li, Xiaoming
Zhou, Yuejiao
Deng, Huihua
Shen, Zhiyong
author_sort Wu, Yan
collection PubMed
description BACKGROUND: Hair antiretroviral concentrations are an objective and non-invasive measure of adherence to long-term antiretroviral therapy (ART) and can further predict virologic outcomes among people living with HIV/AIDS (PLWH). Zidovudine, one of the mainstream antiretrovirals in China, has been verified to have high reliability in adherence assessment, especially for its hair concentrations. However, data are limited in its predicting virologic outcomes. Therefore, this study aimed to characterize whether hair zidovudine concentrations can predict virologic suppression among Chinese PLWH compared with hair lamivudine concentrations and two self-reported measures, the overall frequency of adherence behaviors and percentage adherence. METHODS: This cross-sectional study randomly recruited 564 PLWH currently treated with zidovudine, lamivudine, and other ART agents (efavirenz, nevirapine, or lopinavir/ritonavir) in Guangxi, China. Hair antiretroviral concentrations were determined using the LC-ESI(+)-MS/MS method. Receiver operating characteristic (ROC) curves were used to estimate the optimal classification thresholds of hair concentrations of zidovudine and lamivudine, and the two self-reported measures. Based on those optimal classification thresholds, logistic regression was used to examine whether those four adherence measures can predict virologic suppression (HIV-1 RNA <200 copies/mL). RESULTS: ROC curves demonstrated good classification performance for association with virologic suppression of zidovudine with the optimal threshold at 58 pg/mg and lamivudine at 255 pg/mg but no self-reported measures. PLWH with hair zidovudine concentrations >58 pg/mg had an adjusted odds ratio (aOR) of 43.191 (95% confidence interval (CI) = 10.171‒183.418, p < 0.001) for virologic suppression. Hair lamivudine concentrations were also associated with virologic suppression (aOR = 10.656, 95% CI = 3.670‒30.943, p < 0.001). However, two self-reported measures did not predict virologic suppression (aORs = 1.157 and 2.488, ps >0.149). CONCLUSION: Hair zidovudine concentrations can be served as an alternative tool for clinically predicting virologic suppression among PLWH in China.
format Online
Article
Text
id pubmed-9357394
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-93573942022-08-08 Hair Zidovudine Concentrations Predict Virologic Outcomes Among People Living with HIV/AIDS in China Wu, Yan Liu, Shuaifeng Chu, Liuxi Zhang, Quan Yang, Jin Qiao, Shan Li, Xiaoming Zhou, Yuejiao Deng, Huihua Shen, Zhiyong Patient Prefer Adherence Original Research BACKGROUND: Hair antiretroviral concentrations are an objective and non-invasive measure of adherence to long-term antiretroviral therapy (ART) and can further predict virologic outcomes among people living with HIV/AIDS (PLWH). Zidovudine, one of the mainstream antiretrovirals in China, has been verified to have high reliability in adherence assessment, especially for its hair concentrations. However, data are limited in its predicting virologic outcomes. Therefore, this study aimed to characterize whether hair zidovudine concentrations can predict virologic suppression among Chinese PLWH compared with hair lamivudine concentrations and two self-reported measures, the overall frequency of adherence behaviors and percentage adherence. METHODS: This cross-sectional study randomly recruited 564 PLWH currently treated with zidovudine, lamivudine, and other ART agents (efavirenz, nevirapine, or lopinavir/ritonavir) in Guangxi, China. Hair antiretroviral concentrations were determined using the LC-ESI(+)-MS/MS method. Receiver operating characteristic (ROC) curves were used to estimate the optimal classification thresholds of hair concentrations of zidovudine and lamivudine, and the two self-reported measures. Based on those optimal classification thresholds, logistic regression was used to examine whether those four adherence measures can predict virologic suppression (HIV-1 RNA <200 copies/mL). RESULTS: ROC curves demonstrated good classification performance for association with virologic suppression of zidovudine with the optimal threshold at 58 pg/mg and lamivudine at 255 pg/mg but no self-reported measures. PLWH with hair zidovudine concentrations >58 pg/mg had an adjusted odds ratio (aOR) of 43.191 (95% confidence interval (CI) = 10.171‒183.418, p < 0.001) for virologic suppression. Hair lamivudine concentrations were also associated with virologic suppression (aOR = 10.656, 95% CI = 3.670‒30.943, p < 0.001). However, two self-reported measures did not predict virologic suppression (aORs = 1.157 and 2.488, ps >0.149). CONCLUSION: Hair zidovudine concentrations can be served as an alternative tool for clinically predicting virologic suppression among PLWH in China. Dove 2022-08-03 /pmc/articles/PMC9357394/ /pubmed/35945983 http://dx.doi.org/10.2147/PPA.S371623 Text en © 2022 Wu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Wu, Yan
Liu, Shuaifeng
Chu, Liuxi
Zhang, Quan
Yang, Jin
Qiao, Shan
Li, Xiaoming
Zhou, Yuejiao
Deng, Huihua
Shen, Zhiyong
Hair Zidovudine Concentrations Predict Virologic Outcomes Among People Living with HIV/AIDS in China
title Hair Zidovudine Concentrations Predict Virologic Outcomes Among People Living with HIV/AIDS in China
title_full Hair Zidovudine Concentrations Predict Virologic Outcomes Among People Living with HIV/AIDS in China
title_fullStr Hair Zidovudine Concentrations Predict Virologic Outcomes Among People Living with HIV/AIDS in China
title_full_unstemmed Hair Zidovudine Concentrations Predict Virologic Outcomes Among People Living with HIV/AIDS in China
title_short Hair Zidovudine Concentrations Predict Virologic Outcomes Among People Living with HIV/AIDS in China
title_sort hair zidovudine concentrations predict virologic outcomes among people living with hiv/aids in china
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357394/
https://www.ncbi.nlm.nih.gov/pubmed/35945983
http://dx.doi.org/10.2147/PPA.S371623
work_keys_str_mv AT wuyan hairzidovudineconcentrationspredictvirologicoutcomesamongpeoplelivingwithhivaidsinchina
AT liushuaifeng hairzidovudineconcentrationspredictvirologicoutcomesamongpeoplelivingwithhivaidsinchina
AT chuliuxi hairzidovudineconcentrationspredictvirologicoutcomesamongpeoplelivingwithhivaidsinchina
AT zhangquan hairzidovudineconcentrationspredictvirologicoutcomesamongpeoplelivingwithhivaidsinchina
AT yangjin hairzidovudineconcentrationspredictvirologicoutcomesamongpeoplelivingwithhivaidsinchina
AT qiaoshan hairzidovudineconcentrationspredictvirologicoutcomesamongpeoplelivingwithhivaidsinchina
AT lixiaoming hairzidovudineconcentrationspredictvirologicoutcomesamongpeoplelivingwithhivaidsinchina
AT zhouyuejiao hairzidovudineconcentrationspredictvirologicoutcomesamongpeoplelivingwithhivaidsinchina
AT denghuihua hairzidovudineconcentrationspredictvirologicoutcomesamongpeoplelivingwithhivaidsinchina
AT shenzhiyong hairzidovudineconcentrationspredictvirologicoutcomesamongpeoplelivingwithhivaidsinchina